Its recent approval for sale in Switzerland has brought droplets of fresh showers on the promising weight loss drug. Lyn Youngman senior marketing executive at Acomplia Rimonabant Pill, “Acomplia conquers yet again with its approval for sale in Switzerland. Although Swiss weight is a small market but nevertheless it marks the spread of Acomplia usage”.

Acomplia received approval for sale in Switzerland on 3rd of April, 2007. it is to used only when other approaches like exercise and regulated dietary habits fail to work in sourcing weight loss. Swiss medical authorities have approved it for usage by individuals with a BMI 30 (obese); and individuals with a BMI 27 with at least one cardio metabolic risk factors.

Weight loss medication, Acomplia is already approved for sale in the UK, France, Germany, Mexico, Ireland, Finland, Norway, Austria, Argentina, amid other countries.